First filing for Otsuka's rebamipide for dry eye
This article was originally published in Scrip
Executive Summary
Otsuka Pharmaceutical has made the first regulatory filing worldwide, in Japan, for an ophthalmic suspension formulation of Mucosta (rebamipide) for the treatment of dry eye.